Quantcast

Latest Novartis Stories

2014-03-18 12:32:29

LONDON, March 18, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis World Adult Vaccines Market - Market OverviewFor much of the 20th century, vaccines were a pharmaceutical success story largely associated with children. Aggressive immunization programs eradicated Polio and Smallpox among developed nations and nearly eliminated Mumps, Pertussis, Measles,...

2014-03-12 08:31:21

ATLANTA, March 12, 2014 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced the promotion of Mike Sullivan to the position of President. Sullivan joined Avion Pharmaceuticals in 2011 as Vice President of Sales and Marketing. Tapped for his expertise in building corporate "start-up" pharmaceutical organizations, he has been instrumental in the commercial development, infrastructure and successful launch of Avion over the past three years....

2014-03-03 00:20:29

BASEL, Switzerland, March 3, 2014 /PRNewswire/ -- -- ELATUS((TM)) fungicide receives regulatory approval in Brazil -- Delivers outstanding control of soybean rust disease -- Higher and more predictable yields for Latin American growers Syngenta today announced that ELATUS, a breakthrough foliar fungicide, has been approved by the Brazilian authorities. ELATUS is a combination of Syngenta's new SDHI chemistry SOLATENOL((TM) )and AMISTAR(®). It offers unrivaled performance...

2014-02-27 12:27:41

LONDON, Feb. 27, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Global Parkinson's Disease Market 2012-2016 TechNavio's analysts forecast the Global Parkinson's Disease market to grow at a CAGR of 1.67 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in the aging population. The Global Parkinson's Disease market has also been witnessing the transition toward using drugs that have new...

2014-02-26 08:28:23

DORVAL QC, Feb. 26, 2014 /CNW/ - Novartis announced today that Bexsero(®) (Multicomponent Meningococcal B Vaccine [recombinant, adsorbed]) is now available to doctors and pharmacists across Canada. The vaccine is approved for use in individuals from two months through 17 years of age in Canada. Infants, toddlers and adolescents are at the greatest risk of meningococcal serogroup B (MenB) infection.(1) Bexsero(®) is the first broad-coverage vaccine to help protect against MenB...

2014-02-24 08:29:46

SAN DIEGO, Feb. 24, 2014 /PRNewswire/ -- Thesan Pharmaceuticals announced today the closing of a $49M Series B financing, led by Novo Ventures (a current Investor), with SV Life Sciences and Lundbeckfond Ventures joining Novartis Venture Fund in the syndicate. Thesan's mission is the development of novel approaches for the treatment of dermatological disorders, including acne and atopic dermatitis. "Our focus remains the development of new chemical entities with novel mechanisms of...

2014-02-24 08:28:29

- FDA granted special use of Bexsero for nearly 20,000 UCSB students and staff in response to outbreak; the vaccine is licensed in Europe, Australia and Canada CAMBRIDGE, Mass., Feb. 24, 2014 /PRNewswire/ -- Novartis announced today that its meningococcal serogroup B (MenB) vaccine, Bexsero(®) (Meningococcal Group B Vaccine [rDNA, component, adsorbed]), will be used as part of a vaccination program at the University of California Santa Barbara (UCSB) that began today and will end on March 7....

2014-02-20 12:23:17

- Agrisure Duracade(TM) introductory launch program "Right to Grow" offers farmers step-change in corn rootworm control and 2014 grain marketing options MINNETONKA, Minn., Feb. 20, 2014 /PRNewswire/ -- Syngenta announced today an agreement with Gavilon Grain, LLC that provides grain marketing opportunities for farmers who choose to plant Agrisure Duracade, the cutting-edge corn rootworm (CRW) control technology that has been approved in the U.S. For farmers participating in the...

2014-02-19 16:21:15

DUBLIN, Feb. 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/frs7k2/animalveterinary ) has announced the addition of the "Concise Analysis of the International Animal/Veterinary Vaccines Market - Global Forecast to 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The animal vaccines market studied is segmented by products, animal diseases, and technologies that are involved in developing vaccines for...

2014-02-17 23:02:57

ChinaMarketResearchReports.com adds Latest Report on “Investigation Report on China Valsartan Market, 2009-2018” to its store. Dallas, TX (PRWEB) February 17, 2014 Valsartan (Angiotan or Diovan) is an angiotensin II receptor antagonist (more commonly called an ARB, or angiotensin receptor blocker), with particularly high affinity for the type I (AT1) angiotensin receptor. In December 1996, Valsartan was approved by FDA. In the US, UK and Australia, valsartan is marketed by Novartis...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related